CNBCLean R·
Moderna is now overvalued after cancer vaccine-led stock surge, Rothschild & Co. says
The research firm downgraded the biotechnology stock to sell from neutral.
Read at CNBC →
BBC
The research firm downgraded the biotechnology stock to sell from neutral.
<iframe src="https://statesidedaily.com/embed/cluster/12dd9321ea983af24af8db97bcc21f67f71c698c" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Moderna is now overvalued after cancer vaccine-led stock surge, Rothschild & Co. says"></iframe>
